Solaris Endovascular, Inc. announced that the FDA has granted Breakthrough Device designation for its Solaris DE drug-eluting ...

A comparative analysis from the ENGULF trial demonstrated that using blood return during continuous aspiration thrombectomy ...

Hjarta Care announced that the FDA has granted de novo authorization for the EVAR XplantR, which is a purpose-built, ...

April 29, 2026—enVVeno Medical Corporation announced it has received an FDA investigational device exemption (IDE) for the pivotal study of the ...

Cagent Vascular announced the publication of data demonstrating the safety and efficacy of the company’s Serranator percuta ...

Cydar Medical, a developer of cloud-based artificial intelligence solutions for endovascular surgery, announced an expanded relea ...

Angiolutions announced the appointment of four internationally recognized vascular and endovascular specialists to its ...

Recent findings from a substudy of DETOUR2 demonstrated that percutaneous transmural arterial bypass (PTAB) may offer an ...

Concept Medical Inc. announced preliminary 3-year follow-up data from the SIRONA randomized trial comparing the company’s M ...

Reva Medical, LLC announced primary endpoint results from the pivotal MOTIV BTK randomized clinical trial evaluating the safety a ...

Vena Medical, a Kitchener, Canada—based developer of direct intravascular imaging systems, announced completion of the firs ...

Gore & Associates announced that its Excluder thoracoabdominal branch endoprosthesis (TAMBE) received CE Mark approval earlie ...